Regulus Therapeutics Inc. buy Oppenheimer Holdings Inc.
Start price
14.08.24
/
50%
€1.39
Target price
14.08.25
€6.36
Performance (%)
0.00%
Price
14.08.24
€1.39
Summary
This prediction is currently active. Oppenheimer_Holdings's BUY prediction for Regulus Therapeutics Inc. is currently unchanged. This prediction currently runs until 14.08.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Regulus Therapeutics Inc. | 0.00% |
| iShares Core DAX® | 2.687% |
| iShares Nasdaq 100 | 5.569% |
| iShares Nikkei 225® | 3.756% |
| iShares S&P 500 | 3.959% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $7.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat